Skip to main content
MedinCell launches Regulatory Development of mdc-WWM Program
April 22, 2020
MedinCell has launched a COVID-19 research initiative based on its experience to formulate long-acting injectable Ivermectin
April 6, 2020
MedinCell receives $ 6.4 million grant from Unitaid to fight Malaria
March 25, 2020
MedinCell provides a portfolio update for J.P. Morgan Healthcare Conference 2020
January 13, 2020
MedinCell receives $19 million grant for its mdc-WWM program
November 28, 2019
MedinCell announces that mdc-CWM progresses as planned
September 25, 2019
Long-acting injectable antipsychotic using MedinCell’s technology receives FDA IND clearance to initiate clinical activities
August 26, 2019
MedinCell receives funding for the second formulation phase of its 6-month injectable contraceptive
January 24, 2019
MedinCell receives grant to develop long-acting injectable contraceptive
December 7, 2017
